Skip to main content
FinSpry Logo
FinSpry
NVCR logo
NVCR
(NASDAQ)
NovoCure Limited
$16.85-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

NovoCure (NVCR) Stock Price & Financial Analysis

NovoCure Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$16.57 - $17.78
52-Week High$21.45
52-Week Low$9.82
Open$17.64
Volume1.46M
Average Volume (3M)1.18M
Market Cap2.08B
Shares Outstanding116.01M
Price to Sales (P/S)2.98
Price to Book (P/B)6.16
EV/EBITDA-21.10
Revenue (TTM)699.19M
Net Income (TTM)-148.56M
Free Cash Flow (TTM)-25.43M
EPS (TTM)$-1.31
Profit Margin-21.25%
Operating Margin-22.08%
Return on Equity (ROE)-43.94%
Debt to Equity0.58
50-Day MA$16.82
200-Day MA$14.38
52-Week Change33.73%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About NovoCure

What is the current stock price for NVCR?

As of the latest trading session, NVCR stock trades at $16.85. The 52-week range is $9.82–$21.45, with a day range of $16.57–$17.77.

What is the P/E ratio for NVCR?

The P/E ratio (Price-to-Earnings) for NVCR is shown in the Key Statistics section. This valuation metric helps compare NovoCure Limited to industry peers.

Does NVCR pay dividends?

NovoCure does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for NVCR?

Based on 3 analysts, the consensus for NVCR is Hold.

What is the market cap of NVCR?

NovoCure's market capitalization is $1.95B, classifying it as a small-cap company. NovoCure operates in the Healthcare sector within the Medical Devices industry.